PR PolyResearch

Join Free

NASDAQ

Surgery Partners, Inc. (SGRY)

♥ 511 Thanks from members

Surgery Partners, Inc. (SGRY) displays mixed market sentiment as modest Q2 2026 revenue growth and reaffirmed annual guidance are counterbalanced by ongoing net losses, margin pressures, and a slower M&A pace.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Superior Group of Companies, Inc. (SGC)

AbCellera Biologics Inc. - Common Shares (ABCL)

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)